Abstract
AbstractHepatitis B and C virus, Opisthorchis viverrini and Clonorchis sinensis, are all individually known to put a person at increased risk for cholangiocarcinoma and hepatocellular carcinoma. This paper seeks to determine if there is any interaction between liver flukes and hepatitis virus infection that are known to put a person at an increased risk for cholangiocarcinoma and hepatocellular carcinoma collectively. This paper seeks to determine whether there is any publicly available articles in English that determine if having a hepatitis viral co-infection along with liver flukes would influence the risk of developing liver cancer. We followed PRISMA systematic review guidelines to conduct a literature review. Three manuscripts fit the search criteria. Two presented evidence in support of a synergistic relationship between liver fluke and viral hepatitis infection while the other found no relationship. One manuscript determined that the interaction between hepatitis B and C. sinensis did not have any significant risk of liver cancer. Studies found that HBV affected progression of co-infection to liver cancer but may have its own disease state worsened by presence of liver flukes. Only one paper was found that presented data on HCV, therefore no conclusion can be drawn due to the lack of evidence discovered. Of the studies, the conclusions and strength of the data were mixed. However, the stronger studies suggested a synergistic relationship between liver flukes and HBV to increase the risk of progressing to liver cancer.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Chen MS Jr. Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J Gastroenterol. 2015;21(42):11924. https://doi.org/10.3748/wjg.v21.i42.11924.
2. Dunn, R., Musabaev, E., Razavi, H., Sadirova, S., Bakieva, S., Razavi-Shearer, K., Brigida, K., Kamili, S., Averhoff, F., & Nasrullah, M. (2020). Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model—Tashkent, Uzbekistan, December 6, 2019–March 15, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(34), 1161–1165. https://doi.org/10.15585/mmwr.mm6934a3
.
3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-1273.e1. https://doi.org/10.1053/j.gastro.2011.12.061.
4. Harinasuta C, Harinasuta T. Opisthorchis viverrini: Life cycle, intermediate hosts, transmission to man and geographical distribution in Thailand. Arzneimittelforschung. 1984;34(9B):1164–7.
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;92(61):1-241.